@article{ff62b2583eae4f83b218cbaa8ee9f75a,
title = "Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness",
abstract = "The DNA methylation regulators DNMT3A and TET2 are recurrently mutated in hematological disorders. Despite possessing antagonistic biochemical activities, loss-of-function murine models show overlapping phenotypes in terms of increased hematopoietic stem cell (HSC) fitness. Here, we directly compared the effects of these mutations on hematopoietic progenitor function and disease initiation. In contrast to Dnmt3a-null HSCs, which possess limitless self-renewal in vivo, Tet2-null HSCs unexpectedly exhaust at the same rate as control HSCs in serial transplantation assays despite an initial increase in self-renewal. Moreover, loss of Tet2 more acutely sensitizes hematopoietic cells to the addition of a common co-operating mutation (Flt3ITD) than loss of Dnmt3a, which is associated with a more rapid expansion of committed progenitor cells. The effect of Tet2 mutation manifests more profound myeloid lineage skewing in committed hematopoietic progenitor cells rather than long-term HSCs. Molecular characterization revealed divergent transcriptomes and chromatin accessibility underlying these functional differences.",
keywords = "DNMT3A, TET2, clonal hematopoiesis, hematopoietic stem cell",
author = "Ostrander, {Elizabeth L.} and Kramer, {Ashley C.} and Cates Mallaney and Hamza Celik and Koh, {Won Kyun} and Jake Fairchild and Emily Haussler and Zhang, {Christine R.C.} and Challen, {Grant A.}",
note = "Funding Information: The authors have no conflicting financial interests. This work was supported by the NIH ( R01DK102428 ), the American Society of Hematology , the Longer Life Foundation , the Edward Mallinckrodt, Jr. Foundation , and Gabrielle's Angel Foundation (to G.A.C.). E.L.O. was supported by NIH 5T32CA113275-10 and NIH F31DK114951 . C.M. was supported by NIH T32HL007088 and NIH DK111058-01 . H.C. was supported by an Edward P. Evans Foundation Young Investigator Award. G.A.C. is a scholar of the Leukemia and Lymphoma Society. Funding Information: The authors have no conflicting financial interests. This work was supported by the NIH (R01DK102428), the American Society of Hematology, the Longer Life Foundation, the Edward Mallinckrodt, Jr. Foundation, and Gabrielle's Angel Foundation (to G.A.C.). E.L.O. was supported by NIH 5T32CA113275-10 and NIH F31DK114951. C.M. was supported by NIH T32HL007088 and NIH DK111058-01. H.C. was supported by an Edward P. Evans Foundation Young Investigator Award. G.A.C. is a scholar of the Leukemia and Lymphoma Society. Publisher Copyright: {\textcopyright} 2020 The Authors",
year = "2020",
month = apr,
day = "14",
doi = "10.1016/j.stemcr.2020.02.011",
language = "English",
volume = "14",
pages = "551--560",
journal = "Stem Cell Reports",
issn = "2213-6711",
number = "4",
}